|
3.4.1 CHIMIOPRÉVENTION - ASPIRINE
|
|
|
|
4.10 DÉP., DIAG. & PRONO. - POUMON
|
|
|
|
4.12 BIOPSIES LIQUIDES
|
|
|
Microbiome-Based Cancer Dx Emerges From Cancer Genome Atlas Reanalysis [Genome Web]
|
|
|
|
|
|
The researchers also examined whether blood-based microbial DNA (mbDNA) could be clinically informative in cancer by applying their machine learning models to the WGS data from TCGA blood samples. They found that blood-borne mbDNA could discriminate between numerous types of cancer, regardless of the microbial taxonomic algorithm and database used for classification.
|
|
|
|
|
|
|
|
AI finds microbial signatures in tumours and blood across cancer types [Nature]
|
|
|
|
|
|
Finally, further mechanistic insights into how microbes enter and persist in cancerous tissue are needed, as well as research into how best to target them for treatment and even cancer prevention. Such strategies will need to be nuanced, and must take into account the potential effect on all microbial niches, because many of the body’s resident microbes have a crucial role in overall physiology.
|
|
|
|
|
|
|
4.2 DÉP., DIAG. & PRONO. - GÉNOME
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
|
|
|
5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE
|
|
|
|
5.12.2.1 IMMUNOTHÉRAPIES CAR-NK
|
|
|
|
|
5.12.4 IMMUNOTHÉRAPIES - ESSAIS
|
|
|
|
5.12.5.1 IMMUNOTHÉRAPIES - BIOTECH
|
|
|
|
|
5.12.6 IMMUNOTHÉRAPIES - AMM
|
|
|
|
|
|
|
5.2 PHARMA
|
|
|
|
|
|
5.2.3 PHARMA - ÉCONOMIE
|
|
|
|
5.4 TRAITEMENTS - ECONOMIE
|
|
|
|
5.9 AACR
|
|
|
|
|
6.6 PUBLICATIONS, POLITIQUES SCIENTIFIQUES
|
|
|
|
6.7.1 IA/BIOINFORMATIQUE
|
|
|
|
6.9 CONTROVERSES
|
|
|